Canlyniadau Chwilio - Estelle Cassoly
- Dangos 1 - 3 canlyniadau o 3
-
1
Occupational health risks of pathologists - results from a nationwide online questionnaire in Switzerland gan Florian Fritzsche, Constanze Ramach, Davide Soldini, Rosmarie Caduff, Marianne Tinguely, Estelle Cassoly, Holger Moch, Antony Stewart
Cyhoeddwyd 2012Artigo -
2
Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial gan Gerhardt Attard, Matthew R. Sydes, Malcolm D. Mason, Noel W. Clarke, Daniel M. Aebersold, Johann S. de Bono, David P. Dearnaley, Chris Parker, A.W.S. Ritchie, John M. Russell, George N. Thalmann, Estelle Cassoly, Robin Millman, David Matheson, Francesca Schiavone, Melissa Spears, Mahesh Parmar, Nicholas D. James
Cyhoeddwyd 2014Editorial -
3
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controll... gan Malcolm D. Mason, Noel W. Clarke, Nicholas D. James, David P. Dearnaley, Melissa Spears, A.W.S. Ritchie, Gerhardt Attard, William Cross, Robert J. Jones, Christopher Parker, John M. Russell, George N. Thalmann, Francesca Schiavone, Estelle Cassoly, David Matheson, Robin Millman, Cyrill A. Rentsch, Jim Barber, Clare Gilson, Azman Ibrahim, John Logue, Anna Lydon, Ashok Nikapota, Joe M. O’Sullivan, Emilio Porfiri, Andrew Protheroe, Narayanan Srihari, David Tsang, John Wagstaff, Jan Wallace, Catherine Walmsley, Mahesh Parmar, Matthew R. Sydes
Cyhoeddwyd 2017Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Cancer
Internal medicine
Oncology
Prostate cancer
Urology
Abiraterone
Adverse effect
Androgen
Androgen deprivation therapy
Androgen receptor
Biostatistics
Business
Computer-assisted web interviewing
Confidence interval
Economic growth
Economics
Environmental health
Enzalutamide
Epidemiology
Family medicine
Hazard ratio
Health care
Hormone
Interim analysis
Marketing
Occupational safety and health
Pathology
Population
Prednisone